Long‐term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis-Reference-Cited by-同舟云学术

Long‐term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis

Published:2021-07-08 Issue:9 Volume:28 Page:1293-1303
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Kumada Takashi¹^ORCID,Toyoda Hidenori²^ORCID,Yasuda Satoshi²,Tada Toshifumi³^ORCID,Ito Takanori⁴,Tanaka Junko⁵^ORCID

Affiliation:

1. Department of Nursing Faculty of Nursing Gifu Kyoritsu University Ogaki Gifu Japan

2. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki Gifu Japan

3. Department of Internal medicine Himeji Red Cross Hospital Himeji Hyogo Japan

4. Department of Gastroenterology and Hepatology Nagoya University Graduate School of Medicine Nagoya Aichi Japan

5. Department of Epidemiology Infectious Disease Control, and Prevention Hiroshima University Institute of Biomedical and Health Sciences Hiroshima Japan

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13562

Reference43 articles.

1. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

2. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

3. Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

4. Impact of Sustained Virologic Response with Direct‐Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease

5. Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ein umfassendes Screening auf Hepatitis B und C ist eine effektive Krebsprävention und die Voraussetzung für die Elimination dieser Infektionen – Daten und Anmerkungen zu einer Diskussion;DMW - Deutsche Medizinische Wochenschrift;2023-02